What is vectura?

Vectura is a UK-based drug delivery and development company that specializes in inhaled therapeutics. The company was founded in 1997 and has since grown to become a global leader in the development of innovative inhalation devices and formulations. Vectura works with pharmaceutical companies to develop inhaled drugs for conditions such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. The company’s products include inhalers, nebulizers, and dry powder inhalers, which allow patients to receive medication directly into their lungs. Vectura is also involved in the development of new treatments for respiratory diseases, as well as non-respiratory diseases such as cancer and diabetes. The company is headquartered in Chippenham, UK, and has offices in Germany, Switzerland, and the US. In 2021, Vectura was acquired by pharmaceutical company Philip Morris International.